297 related articles for article (PubMed ID: 10330423)
21. Type I and type II interleukin-1 receptor expression in rat, mouse, and human testes.
Gomez E; Morel G; Cavalier A; Liénard MO; Haour F; Courtens JL; Jégou B
Biol Reprod; 1997 Jun; 56(6):1513-26. PubMed ID: 9166705
[TBL] [Abstract][Full Text] [Related]
22. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone.
Martin-Millan M; Almeida M; Ambrogini E; Han L; Zhao H; Weinstein RS; Jilka RL; O'Brien CA; Manolagas SC
Mol Endocrinol; 2010 Feb; 24(2):323-34. PubMed ID: 20053716
[TBL] [Abstract][Full Text] [Related]
23. Soluble interleukin-1 receptor, a potential negative regulator of orange-spotted grouper Epinephelus coioides interleukin-1 system.
Lu DQ; Yao M; Yi SB; Li YW; Liu XC; Zhang Y; Lin HR
J Fish Biol; 2013 Sep; 83(3):642-58. PubMed ID: 23991879
[TBL] [Abstract][Full Text] [Related]
24. Extracellular regulation of interleukin (IL)-1beta through lung epithelial cells and defective IL-1 type II receptor expression.
Coulter KR; Wewers MD; Lowe MP; Knoell DL
Am J Respir Cell Mol Biol; 1999 May; 20(5):964-75. PubMed ID: 10226066
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization and functional expression of equine interleukin-1 type I and type II receptor cDNAs.
Kirisawa R; Hashimoto N; Tazaki M; Yamanaka H; Ishii R; Hagiwara K; Iwai H
Vet Immunol Immunopathol; 2006 Feb; 109(3-4):219-31. PubMed ID: 16176839
[TBL] [Abstract][Full Text] [Related]
26. Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women.
Kassem M; Khosla S; Spelsberg TC; Riggs BL
J Clin Endocrinol Metab; 1996 Feb; 81(2):513-8. PubMed ID: 8636260
[TBL] [Abstract][Full Text] [Related]
27. Effect of interleukin-1beta on aromatase activity and cell proliferation in human osteoblast-like cells (HOS).
Morioka M; Shimodaira K; Kuwano Y; Fujikawa H; Saito H; Yanaihara T
Biochem Biophys Res Commun; 2000 Feb; 268(1):60-4. PubMed ID: 10652212
[TBL] [Abstract][Full Text] [Related]
28. IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes.
Dickensheets HL; Donnelly RP
J Immunol; 1997 Dec; 159(12):6226-33. PubMed ID: 9550426
[TBL] [Abstract][Full Text] [Related]
29. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
[TBL] [Abstract][Full Text] [Related]
30. The membrane form of the type II IL-1 receptor accounts for inhibitory function.
Neumann D; Kollewe C; Martin MU; Boraschi D
J Immunol; 2000 Sep; 165(6):3350-7. PubMed ID: 10975853
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of type II interleukin-1 receptors by human corneal epithelial cells but not by keratocytes.
Cubitt CL; Lausch RN; Oakes JE
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):701-4. PubMed ID: 11222530
[TBL] [Abstract][Full Text] [Related]
32. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
Chabaud M; Miossec P
Arthritis Rheum; 2001 Jun; 44(6):1293-303. PubMed ID: 11407688
[TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA.
Liu C; Hart RP; Liu XJ; Clevenger W; Maki RA; De Souza EB
J Biol Chem; 1996 Aug; 271(34):20965-72. PubMed ID: 8702856
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 27 (IL-27) Alleviates Bone Loss in Estrogen-deficient Conditions by Induction of Early Growth Response-2 Gene.
Shukla P; Mansoori MN; Kakaji M; Shukla M; Gupta SK; Singh D
J Biol Chem; 2017 Mar; 292(11):4686-4699. PubMed ID: 28130449
[TBL] [Abstract][Full Text] [Related]
35. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.
Bessis N; Guéry L; Mantovani A; Vecchi A; Sims JE; Fradelizi D; Boissier MC
Eur J Immunol; 2000 Mar; 30(3):867-75. PubMed ID: 10741403
[TBL] [Abstract][Full Text] [Related]
36. Estrogen and bone metabolism.
Väänänen HK; Härkönen PL
Maturitas; 1996 May; 23 Suppl():S65-9. PubMed ID: 8865143
[TBL] [Abstract][Full Text] [Related]
37. Selectivity release of the type II decoy IL-1 receptor.
Orlando S; Polentarutti N; Mantovani A
Cytokine; 2000 Jul; 12(7):1001-6. PubMed ID: 10880245
[TBL] [Abstract][Full Text] [Related]
38. IL-1alpha and IL-1beta have different effects on formation and activity of large osteoclasts.
Trebec-Reynolds DP; Voronov I; Heersche JN; Manolson MF
J Cell Biochem; 2010 Apr; 109(5):975-82. PubMed ID: 20108252
[TBL] [Abstract][Full Text] [Related]
39. Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study.
Durand M; Komarova SV; Bhargava A; Trebec-Reynolds DP; Li K; Fiorino C; Maria O; Nabavi N; Manolson MF; Harrison RE; Dixon SJ; Sims SM; Mizianty MJ; Kurgan L; Haroun S; Boire G; de Fatima Lucena-Fernandes M; de Brum-Fernandes AJ
Arthritis Rheum; 2013 Jan; 65(1):148-58. PubMed ID: 23044761
[TBL] [Abstract][Full Text] [Related]
40. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.
Hughes DE; Dai A; Tiffee JC; Li HH; Mundy GR; Boyce BF
Nat Med; 1996 Oct; 2(10):1132-6. PubMed ID: 8837613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
